Functional mushrooms have become one of the top health and wellness stories.
After all, specific types of mushrooms have been shown to help increase mental clarity, and assist with immune support. According to Mordor Intelligence, “A number of scientific studies have confirmed the ability of functional mushrooms and mushroom-derived supplements to increase the effectiveness of both innate and adaptive immune systems. The market is expected to experience huge demand for Reishi and Cordyceps, followed by the other types of medicinal mushrooms.”
Even Lion’s Mane for example has been shown to be good for the brain, as reported by The New York Times. It’s “believed by many consumers to be good for the brain, and a study published in 2011 showed the mushroom reduced memory loss symptoms in mice,” adding that in one study in older people “found that daily lion’s mane supplements improved their mental functioning.
Mushrooms in general have some really great benefits,” says dietitian Ryanne Lachman, as quoted by the Cleveland Clinic. “A big one tends to be with reducing inflammation. Mushrooms also contain antioxidants, which can help support the immune system.”
That news is beneficial for companies such as New Wave Holdings Corp. (CSE:SPOR) (OTC:TRMNF), HAVN Life Sciences (CSE:HAVN), Halo Collective Inc. (NEO:HALO)(OTC:HCANF), and Numinus Wellness Inc. (TSXV:NUMI).
Arev NanoTec Brands Inc. (CSE: AREV)(OTC: AREVF) Also Benefits
AREV, which produces functional ingredients through its proprietary extraction systems and methods for the natural health, medical, functional food, nutraceutical, sport nutrition markets, just announced the appointment of Dr. Jay Noller to its Scientific Advisory Board.
In addition, the company just announced its subsidiary AREV Cambodia Brands Inc. has initiated the first of several steps to setting up a permaculture operation on 20 hectares of land near Phnom Penh to support the development of the raw materials for product innovations in development for introduction to market in the 3rd Quarter of 2021.
Our first product category is a Ready-to-Use Therapeutic Food or “RUTF”. Several ingredients will be produced using AREV’s proprietary extraction methodologies, including selected fungi that will be used in “SUS-TAINN™”, our branded RUTF formulation. Mycelium are a known source of sustainable protein, which has been neglected in the development of other RUTF formulas currently distributed in significant volume in resource poor settings by numerous public health commodity procurement agencies. Examples include the World Food Program and USAID utilizing RUTFs to address severe and chronic malnutrition, a condition that exacerbates pandemic diseases and associated co-morbidities.
Ready To Use Therapeutic Foods (RUTFs) are designed for specific, nutritional, therapeutic purposes, are composed of a mixture of protein, carbohydrate, lipid, and vitamins and minerals. The primary examples of therapeutic food use are emergency feeding of malnourished children and supplementing the diets of persons with special nutrition requirements. RUTFs are energy-dense, micronutrient-enriched pastes that have a nutritional profile similar to the traditional F-100 milk-based diet used for inpatient therapeutic feeding programs and are often made of peanuts, oil, sugar and milk powder.
Roscoe M. Moore, Jr., DVM, MPH, PhD, Former US Assistant Surgeon General (retired) and a board member of the Global Virus Network at the Institute of Human Virology, University of Maryland, who serves as the Senior Scientific Advisor for AREV stated, “Unlike the majority of other RUTFs on the market, AREV Nanotech’s SUS-TAINN ™ (Superior Utility Supplementation Therapeutic Agent for Indicated Nutritional Needs) is being developed to address the disparities in current therapeutic strategies to address chronic and severe malnutrition in resource poor settings. Too often international humanitarian agencies cannot adjust their procurement strategies based on fluctuating capital structures that determine access to essential public health commodities.”
Jay Stratton Noller, PhD, MS, Professor Emeritus, Oregon State University (“OSU”) and the founding Director and lead researcher of OSU’s Global Hemp Innovation Center, and a recently appointed member of AREV’s Scientific Advisory Board, stated, “Mushrooms secrete extracellular enzymes that allow them to assimilate nutrients by the absorption of the simple molecules that are created following the enzymatic degradation process. Mushrooms are naturally rich in proteins, fiber, carbohydrates, vitamins, and minerals and are low in calories and fats, especially cholesterol, making them a very viable addition to the current capacities of RUTF utility. Numerous noted clinical investigators have identified the medicinal utility of a wide range of species of mycopia and their value in human nutrition. SUS-TAINN will the first RUTF to explore the utility of mycopia addressing chronic malnutrition.”
Mike Withrow, CEO stated, “We continue to build and secure our supply chain ingredients for use in our formulations. This is critical to ensure we have quality ingredients and reliable access to raw materials to be extracted into the key products we are developing to address malnutrition in the context of the increasing viral pandemics of our contemporary world. Our development with the Phnom Penh agriculture initiative to cultivate mycelium for the market introduction of SUS-TAINN will ensure that the raw material sourcing is not subject to the dramatic price fluctuations consistently demonstrated across international commodities markets”.
AREV NanoTec Brands Inc. produces phytomedicinal extracts via its proprietary state-of-the-art extraction methodologies for the life science industry. These premium ingredients and products are targeted for the medical, functional food, and enteral formula markets. AREV Brand’s model is to advance medicinal extraction technologies that provide opportunities for next generation phytomedicine.
Legal Disclaimer / Except for the historical information presented herein, matters discussed in this article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. Winning Media is only compensated for its services in the form of cash-based compensation. Pursuant to an agreement Winning Media has been paid three thousand five hundred dollars for advertising and marketing services for Arev NanoTec Brands Inc. by a third party. We own ZERO shares of Arev NanoTec Brands Inc. Please click here for full disclaimer.